Biohaven Pharmaceutical Holding Stock Momentum Indicators Average Directional Movement Index

BHVN Stock  USD 45.23  0.36  0.79%   
Biohaven Pharmaceutical momentum indicators tool provides the execution environment for running the Average Directional Movement Index indicator and other technical functions against Biohaven Pharmaceutical. Biohaven Pharmaceutical value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Average Directional Movement Index indicator function is designed to identify and follow existing trends. Momentum indicators of Biohaven Pharmaceutical are pattern recognition functions that provide distinct formation on Biohaven Pharmaceutical potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify Time Period to run this model.

Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The average directional index (ADX) measures the strength of a prevailing trend of Biohaven Pharmaceutical and whether movement exists in the market. The ADX is measured on a scale of 0 to 100. A low Biohaven Pharmaceutical ADX value usually indicates a non-trending market with low volumes, whereas a cross above 20 may indicate the start of a trend. If the ADX is over 40 and begins to fall, it can indicate the slowdown of a current trend. This indicator can also be used to identify non-trending markets, or a deterioration of an ongoing trend. Although market direction is important in its calculation, the ADX is not a directional indicator

Biohaven Pharmaceutical Technical Analysis Modules

Most technical analysis of Biohaven Pharmaceutical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biohaven from various momentum indicators to cycle indicators. When you analyze Biohaven charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Biohaven Pharmaceutical Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biohaven Pharmaceutical Holding. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biohaven Pharmaceutical Holding based on widely used predictive technical indicators. In general, we focus on analyzing Biohaven Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biohaven Pharmaceutical's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Biohaven Pharmaceutical's intrinsic value. In addition to deriving basic predictive indicators for Biohaven Pharmaceutical, we also check how macroeconomic factors affect Biohaven Pharmaceutical price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Payables Turnover19.20.130.220.21
Days Of Inventory On Hand26.8114.8K17.0K16.2K
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biohaven Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
41.6845.2348.78
Details
Intrinsic
Valuation
LowRealHigh
41.4344.9848.53
Details
15 Analysts
Consensus
LowTargetHigh
25.6628.2031.30
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-2.18-2.15-2.13
Details

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Biohaven Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biohaven Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biohaven Pharmaceutical Holding Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biohaven Pharmaceutical Holding Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.37)
Return On Assets
(1.19)
Return On Equity
(2.65)
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.